Research
Jan 8, 2023
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. ICAP...
Jan 6, 2023
This study investigated the experimental microbicide gel tenofovir to protect women against HIV. The study provided information on how much vaginal tenofovir gel, when used in combination with common vaginal products, will interfere with the local and or systemic...
Jan 3, 2023
ICAP is conducting formative research to inform the design and implementation of combination prevention interventions, including pre-exposure prophylaxis (PrEP) for female sex workers, as well as to inform recruitment and retention strategies for female sex workers...
Jan 1, 2023
ICAP is conducting a study to assess the feasibility, acceptability and retention in PrEP among the fisherfolk population at Jaramogi Oginga Odinga Teaching and Referral Hospital, which ICAP supports. The study will include provision of PrEP in addition to HIV...
Dec 23, 2022
This was a small mixed-methods study to explore barriers and facilitators of male engagement in CARGs in Zimbabwe. Results were used to inform policy and efforts to enhance the coverage, quality, and impact of HIV services by optimizing differentiated care for men....
